Market closed
Abbott/$ABT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Ticker
$ABT
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
114,000
Website
Abbott Metrics
BasicAdvanced
$198B
Market cap
34.72
P/E ratio
$3.29
EPS
0.72
Beta
$2.20
Dividend rate
2.07%
Dividend yield
Price and volume
Market cap
$198B
Beta
0.72
52-week high
$121.64
52-week low
$99.71
Average daily volume
5.1M
Dividend rate
$2.20
Financial strength
Current ratio
1.597
Quick ratio
0.996
Long term debt to equity
32.175
Total debt to equity
37.525
Dividend payout ratio (TTM)
65.30%
Interest coverage (TTM)
11.86%
Management effectiveness
Return on assets (TTM)
6.49%
Return on equity (TTM)
14.84%
Valuation
Price to earnings (TTM)
34.72
Price to revenue (TTM)
4.824
Price to book
5.05
Price to tangible book (TTM)
24.29
Price to free cash flow (TTM)
30.653
Dividend yield (TTM)
1.93%
Forward dividend yield
2.07%
Growth
Revenue change (TTM)
3.15%
Earnings per share change (TTM)
12.05%
3-year revenue growth (CAGR)
-0.87%
3-year earnings per share growth (CAGR)
-6.54%
3-year dividend per share growth (CAGR)
6.92%
What the Analysts think about Abbott
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Abbott stock.
Abbott Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Abbott Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Abbott News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Abbott stock?
Abbott (ABT) has a market cap of $198B as of December 22, 2024.
What is the P/E ratio for Abbott stock?
The price to earnings (P/E) ratio for Abbott (ABT) stock is 34.72 as of December 22, 2024.
Does Abbott stock pay dividends?
Yes, the Abbott (ABT) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is $2.2 and the yield is 2.07%. Abbott has a payout ratio of 65.3% on a trailing twelve-month basis.
When is the next Abbott dividend payment date?
The next Abbott (ABT) dividend payment date is unconfirmed.
What is the beta indicator for Abbott?
Abbott (ABT) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.